Emma Iles
Emma is a Partner in the Intellectual Property Disputes team.
Emma is a specialist in intellectual property advice and dispute resolution. Emma advises clients in all areas of IP and technology, including patents, trade marks, copyright and confidential information. She also advises clients in relation to therapeutic goods regulations and in consumer law matters, regularly advising clients on advertising, marketing campaigns and disputes, including greenwashing.
Emma has particular expertise in the life sciences sector, with her legal qualifications complemented by a degree in Biomedical Science. Her practice also involves regularly advising clients on regulatory issues relating to pharmaceuticals, radiopharmaceuticals and medical devices. This includes advising on internal investigations relating to regulatory compliance.
Her litigious experience includes urgent interlocutory applications, trade mark office proceedings, multi-jurisdictional patent disputes, international arbitrations and commercial disputes. This experience extends to industries including pharmaceuticals, biotechnology, medical devices, software, and consumer products.
Background
Emma completed her Bachelor of Laws (Honours) and Bachelor of Biomedical Science at Monash University. Emma also has a Masters of Commercial Law from Melbourne University.
She is admitted to practice in the Supreme Court of Victoria, the Federal Court of Australia and the High Court of Australia.
Market Recognition
Emma is recognised by Legal 500 for Intellectual Property and by Chambers in Intellectual Property (Patents) and Life Sciences. She is recognised in Doyle’s Guide as a Leading Contentious Intellectual Property Practitioner, as a Notable Practitioner by IP Stars and is recognised as a ‘Best Lawyer’ for Intellectual Property and Alternative Dispute Resolution.
Experience & expertise
Selected matters
- Multiple global pharmaceutical companies in complex patent infringement and invalidity disputes including Gilead (in relation to a blockbuster HIV treatment), a confidential client (in relation to a blockbuster MS treatment) and Boehringer Ingelheim (in relation to an inhalable formulation for the treatment of COPD)
- Godfrey Hirst in Supreme Court proceedings relating to alleged breaches of contract fiduciary duties, confidentiality and copyright infringement by former employees.
- Isuzu Australia in defending Federal Court proceedings relating to alleged breaches of contract, fiduciary duties, contract and confidentiality and copyright infringement.
- Terra Carbon in defending proceedings in the Federal Court of Australia alleging misuse of trust property and intellectual property infringement.
- Ramsay Health Care Australia in proceedings related to misleading and deceptive conduct in print and radio advertising.
- Advising generative AI developers, and businesses deploying generative AI, in respect of potential IP infringement risks.
- Fonterra Co-operative Group in Australian patent litigation related to recombinant dairy proteins.
- Ruminant Biotechnology in patent proceedings relating to methane emissions reduction technology.
- Tibra Trading in litigation related to Tibra’s algorithmic trading software, concerning copyright infringement and confidential information.
Sectors
